Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose daily dexamethasone vs intermittent dexamethasone vs prednisolone in hormone-refractory prostate cancer
2005-006018-16Phase 3Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jan 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexamethasone and prednisolone in prostate cancer (PCa) (3 arms), sponsored by Royal Marsden NHS Foundation Trust. Primary endpoint: PSA response. Started Jan 2006; status: completed.
02
Drugs
dexamethasoneprednisolone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2005-006018-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006018-16.